Showing results (31-40 of 197) with videos related to
Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|December 26, 2001
Patient's and doctors' delays in the diagnosis of chest tumorsHirsh Koyi, Gunnar Hillerdal, Eva BrandénLung Cancer (Amsterdam, Netherlands)|August 6, 2016
O<sup>6</sup>-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?Birgitta I Hiddinga, Patrick Pauwels, Annelies Janssens, et al.Current Opinion in Pulmonary Medicine|May 26, 2009
What is the role for surgery in patients with stage III non-small cell lung cancer?Elke Vandenbroucke, Frederic De Ryck, Veerle Surmont, et al.Acta Clinica Belgica|January 15, 2020
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS dataBenoît Colinet, Jan P Van Meerbeeck, Tine Cuppens, et al.Oncotarget|September 9, 2017
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Sabrina Lagniau, Kevin Lamote, Jan P van Meerbeeck, et al.Pharmacoeconomics|November 10, 2005
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancerNiels Neymark, Pilar Lianes, Egbert F Smit, et al.Critical Reviews in Oncology/Hematology|May 15, 2010
Malignant pleural mesothelioma: the standard of care and challenges for future managementJan P van Meerbeeck, Arnaud Scherpereel, Veerle F Surmont, et al.Cancers|January 8, 2023
A Cross-Sectional Study on the Acceptability of Implementing a Lung Cancer Screening Program in BelgiumPaloma Diab Garcia, Annemiek Snoeckx, Jan P Van Meerbeeck, et al.Lancet (London, England)|May 14, 2011
Small-cell lung cancerJan P van Meerbeeck, Dean A Fennell, Dirk K M De RuysscherLung Cancer (Amsterdam, Netherlands)|July 12, 2015
Second line therapy in malignant pleural mesothelioma: A systematic reviewWieneke A Buikhuisen, Birgitta I Hiddinga, Paul Baas, et al.Pageof 20